Physician profile
Albert Losken
NPI 1932166766
$435,810.16
in general payments reported to CMS, 2019-2025
24 companies · $120K in 2025
The $120K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $2,658 · 2021: $37K · 2022: $153K · 2023: $33K · 2024: $50K · 2025: $120K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $107K · Consulting Fee: $92K · Food and Beverage: $3,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $106,725.94 |
| Consulting Fee | $92,400.00 |
| Food and Beverage | $3,896.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $164,230.43 | 2021-2025 | |
| Surgical Innovation Associates, INC. | $131,857.00 | 2022 | |
| Bimini Technologies LLC | $92,400.00 | 2025 | |
| Surgalign Spine Technologies, INC. | $41,723.37 | 2019-2020 | |
| Abbvie INC. | $737.71 | 2023-2025 | |
| Mentor Worldwide LLC | $735.02 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Tela Bio, INC. | $699.61 | 2019-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sientra, INC. | $577.74 | 2019-2022 | |
| Kerecis Limited | $400.58 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Dilon Technologies, INC. | $306.43 | 2024-2025 | Hemoblast Bellows |
| Tepha INC | $265.28 | 2019 | |
| Davol INC. | $254.97 | 2022-2025 | |
| Bard Peripheral Vascular, INC. | $220.93 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $212.83 | 2021-2025 | |
| Mesh Suture INC | $199.12 | 2024-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $166.32 | 2019-2022 | |
| Acera Surgical, INC. | $159.53 | 2023 | Restrata Wound Matrix |
| Motiva USA, LLC | $158.53 | 2025 | |
| Axogen | $155.55 | 2022 | |
| Innovation Technologies INC | $140.57 | 2023 | Irrisept |
| Baxter Healthcare | $109.34 | 2025 | Tisseel |
| Integra Lifesciences Corporation | $63.00 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $25.37 | 2020 | |
| Aroa Biosurgery Incorporated | $10.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Losken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.